Literature DB >> 19093092

[Bufexamac-induced pigmented purpuric eruption].

K Waltermann1, W Ch Marsch, B Kreft.   

Abstract

We report on a case of a bufexamac-induced allergic contact dermatitis with hematogenous dissemination presenting with the clinical and histological picture of a pigmented purpuric eruption. To our knowledge this is the first report on a bufexamac-induced pigmented purpuric dermatosis. It represents a further example of the clinical variety of cutaneous side-effects caused by bufexamac.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19093092     DOI： 10.1007/s00105-008-1656-2

Source DB:  PubMed          Journal:  Hautarzt        ISSN： 0017-8470            Impact factor:   0.751


  25 in total

1.  PUVA therapy in lichen aureus.

Authors:  T C Ling; V Goulden; M J Goodfield
Journal:  J Am Acad Dermatol       Date:  2001-07       Impact factor: 11.527

2.  Pigmented purpuric contact dermatitis from Disperse Blue 106 and 124 dyes.

Authors:  P Komericki; W Aberer; E Arbab; Z Kovacevic; B Kränke
Journal:  J Am Acad Dermatol       Date:  2001-09       Impact factor: 11.527

3.  [A common and insidious side-effect: allergic contact dermatitis caused by bufexamac used in the treatment of dermatitis. Results from the Information Network of Departments of Dermatology (IDVK)].

Authors:  A Schnuch; O Gefeller; W Uter
Journal:  Dtsch Med Wochenschr       Date:  2005-12-16       Impact factor: 0.628

4.  Purpuric clothing dermatitis due to Disperse Yellow 27.

Authors:  C Foti; G Elia; R Filotico; G Angelini
Journal:  Contact Dermatitis       Date:  1998-11       Impact factor: 6.600

5.  Purpura pigmentosa chronica successfully treated with oral cyclosporin A.

Authors:  K Okada; O Ishikawa; Y Miyachi
Journal:  Br J Dermatol       Date:  1996-01       Impact factor: 9.302

6.  Bufexamac is a frequent contact sensitizer.

Authors:  B Kränke; J Derhaschnig; P Komericki; W Aberer
Journal:  Contact Dermatitis       Date:  1996-01       Impact factor: 6.600

7.  Immunohistologic studies in Schamberg's disease. Evidence for cellular immune reaction in lesional skin.

Authors:  S Aiba; H Tagami
Journal:  Arch Dermatol       Date:  1988-07

8.  Glipizide-induced pigmented purpuric dermatosis.

Authors:  B B Adams; A S Gadenne
Journal:  J Am Acad Dermatol       Date:  1999-11       Impact factor: 11.527

Review 9.  Persistent pigmented purpuric eruption associated with mycosis fungoides: a case report and review of the literature.

Authors:  S Georgala; A C Katoulis; S Symeonidou; C Georgala; G Vayopoulos
Journal:  J Eur Acad Dermatol Venereol       Date:  2001-01       Impact factor: 6.166

10.  Chronic pigmented purpura associated with odontogenic infection.

Authors:  Takahiro Satoh; Hiroo Yokozeki; Kiyoshi Nishioka
Journal:  J Am Acad Dermatol       Date:  2002-06       Impact factor: 11.527
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.